Stockreport

Palvella Therapeutics Inc (PVLA) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]

Palvella Therapeutics, Inc.  (PVLA) 
PDF Public Offering Proceeds: $215.8 million net from a $230 million offering in February 2026. Pro Forma Cash: $274 million after the public offering. Release Date: Ma [Read more]